Beida Pharmaceutical Co., Ltd. is an innovative drug developer, involving malignant tumors, ophthalmology, autoimmune diseases, diabetes and other fields. Mainly provide users with products such as chlorotinib hydrochloride (Kemena) and anti-tumor drug CM082. New drug research projects include the research and development of Class I and Class II new drugs in 6 countries and Class III and Class IV new drugs in 14 countries.
More peer analysis, the company knows and understands.